TruAlt Bioenergy

Which are the latest news on TruAlt Bioenergy?

Why is TruAlt Bioenergy Ltd falling/rising?

As of 05-Sep, TruAlt Bioenergy Ltd's stock price is declining at 424.70, with a 1-week drop of -2.03% compared to the Sensex's -0.97%. Despite a year-to-date increase of +5.06%, concerns arise from weak fundamentals, high debt levels, and a bearish trend indicated by trading below moving averages.

As of 05-Sep, TruAlt Bioenergy Ltd's stock price is falling, currently at 424.70, reflecting a change of -1.85 (-0.43%). The stock has underperformed relative to the benchmark Sensex, with a 1-week decline of -2.03% compared to the Sensex's -0.97%. Over the past month, the stock has decreased by -2.84%, while the Sensex has fallen by -2.44%. <BR><BR>Despite a year-to-date increase of +5.06%, the stock's performance is concerning due to weak long-term fundamental strength, indicated by an average Return on Capital Employed (ROCE) of 0% and a high Debt to EBITDA ratio of 5.40 times, suggesting a low ability to service debt. Additionally, 36.85% of promoter shares are pledged, which can exert downward pressure on stock prices in falling markets.<BR><BR>While there have been positive results reported for the quarter ending June 26, including significant growth in profit before tax, profit after tax, and net sales, the overall sentiment is affected by the company's declining profits over the past year, which have fallen by -37%. Furthermore, the stock is trading lower than all its moving averages, indicating a bearish trend. <BR><BR>Overall, these factors contribute to the stock's current decline.

Should I buy, sell or hold TruAlt Bioenergy Ltd?

What does TruAlt Bioenergy do?

TruAlt Bioenergy Ltd is a renewable energy company focused on manufacturing and selling ethanol and bioenergy products, with a market cap of INR 3,675 Cr. As of June 2026, it reported net sales of 627 Cr and a net profit of 57 Cr.

Overview: <BR>TruAlt Bioenergy Ltd is a fast-growing renewable energy company engaged in the manufacturing and sale of ethanol and allied bioenergy products, operating within the Commodity Chemicals industry and categorized as a Small Cap company.<BR><BR>History: <BR>TruAlt Bioenergy Ltd was originally incorporated as "TruAlt Energy Limited" on March 31, 2021. The company changed its name to "TruAlt Bioenergy Limited" effective July 1, 2022. The most recent quarterly results reported net sales and net profit for the period ending June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 627 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 57 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 3,675 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 23.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.02 <BR>Return on Equity: 6.84% <BR>Price to Book: 2.45 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the TruAlt Bioenergy?

TruAlt Bioenergy's peers include Tata Chemicals, India Glycols, Tanfac Inds., and others, with varying management risks and growth rates. India Glycols leads with a 41.38% 1-year return, while Fischer Medical has the lowest at -66.23%.

Peers: The peers of TruAlt Bioenergy are Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, J.G.Chemicals, Fischer Medical, and Thirumalai Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, Grauer & Weil, J.G.Chemicals, Fischer Medical, and Thirumalai Chem. Below Average growth is noted for Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, and Thirumalai Chem, while Good growth is seen at J.G.Chemicals and Fischer Medical, with the rest showing Below Average growth. Excellent capital structure is present at Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, and J.G.Chemicals, while Average capital structure is found at Tata Chemicals and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 41.38%, while Fischer Medical has the lowest at -66.23%. TruAlt Bioenergy's 1-year return is not available for comparison. Additionally, Chemplast Sanmar and Fischer Medical have negative six-month returns.

How big is TruAlt Bioenergy?

As of 31st August, TruAlt Bioenergy Ltd has a market capitalization of 3,675.00 Cr, with recent net sales of 2,050.50 Cr and a net profit of 156.41 Cr. The balance sheet for March 2026 shows shareholder's funds of 1,520.33 Cr and total assets of 3,778.34 Cr.

As of 31st August, TruAlt Bioenergy Ltd has a market capitalization of 3,675.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, TruAlt Bioenergy reported Net Sales of 2,050.50 Cr and a Net Profit of 156.41 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, showing Shareholder's Funds of 1,520.33 Cr and Total Assets of 3,778.34 Cr.

Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results show strong year-on-year growth, with net sales up 106.29% and net profit increasing by 1,108.25%. However, sequential declines in profit and margins raise concerns about the sustainability of this growth, indicating a mixed overall performance.

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved impressive year-on-year growth, with net sales increasing by 106.29% to ₹626.88 crores compared to the same quarter last year. This recovery is notable, especially considering the weak performance in the previous year. However, the sequential quarter-on-quarter growth of just 5.27% indicates that the momentum may be slowing down after a strong performance in prior quarters.<BR><BR>In terms of profitability, the net profit for Q1 FY27 was ₹57.15 crores, reflecting an extraordinary year-on-year increase of 1,108.25%. However, this represents a decline of 15.79% compared to the previous quarter, which raises concerns about the sustainability of profit levels. Additionally, while the operating margin improved significantly year-on-year to 21.18%, it did see a slight decline from the previous quarter.<BR><BR>Overall, while the year-on-year growth figures are strong and suggest a recovery from past challenges, the sequential declines in profit and margins indicate potential issues that need to be monitored closely. The company is still navigating through operational volatility and capital efficiency challenges, which could impact its long-term performance. Therefore, the results can be viewed as good in terms of recovery but concerning regarding the sustainability of that growth.

When is the next results date for TruAlt Bioenergy Ltd?

The next results date for TruAlt Bioenergy Ltd is 22 May 2026.

The next results date for TruAlt Bioenergy Ltd is scheduled for 22 May 2026.